Medicine composition for treating upper respiration channel infection and its preparing process

Abstract

A pharmaceutical composition for treating upper respiratory tract infection and its industrially applicable preparation method, which is mainly composed of ethanol and water extracts of Ligustrum lucidum, Radix Astragali, Salvia miltiorrhiza, and lacquer lacquer, which is effective for acute and chronic pharyngitis, bronchitis , tonsillitis, etc., especially for chronic pharyngitis with complex diseases, nourishing the middle to clear, nourishing the middle and transforming, nourishing yin and Qi, resolving phlegm and removing blood stasis, and has the effect of treating both symptoms and root causes. The present invention uses modern extraction technology and pharmacological experiments. Concretely and characteristically present the treatment concept of synergistic multi-target, systemic regulation and local focus treatment unique to traditional Chinese medicine.

Description

technical field

[0001] The invention relates to a medicinal composition for treating upper respiratory tract infection derived from traditional Chinese medicine and a preparation method thereof. Background technique

[0002] Upper respiratory tract infections often cause inflammation of the trachea, throat, and tonsils, and are often closely related to general conditions. The Chinese patent medicines currently on the market for treating upper respiratory tract infection can be divided into two categories: those mainly for clearing away heat and detoxifying throat, which are less effective in treating upper respiratory tract infection; The curative effect of these drugs is better for those with deficiency fire and upper inflammation, but for those with Qi deficiency, especially those with phlegm coagulation and blood stasis syndrome, the curative effect is not good. The current market lacks medicines for the treatment of upper respiratory tract infections such as qi deficien...